Anest. intenziv. Med. 2012;23(1):14-20

Kardiorelax 2011 - a five-day observational study of neuromuscular blockade during adult cardiac surgery in the Czech RepublicAnaesthesiology - Original Paper

Hájek Roman1,*, Adámek Petr2, Derych Leo3, Horáček Michal4, Jehlička Pavel5, Kameník Vladimír6, Leitgeb Marián7, Mokrejš Jiří8, Říha Hynek9, Samek Jindřich10, Schichel Tomáš11, Turek Zdeněk10, Vaněk Tomáš12
1 Kardiochirurgická klinika, LF Univerzity Palackého a Fakultní nemocnice Olomouc
2 Centrum kardiovaskulární a transplantační chirurgie, Brno
3 Kardiochirurgické oddělení, Nemocnice Podlesí, a. s., Třinec
4 Klinika anesteziologie, resuscitace a intenzivní medicíny, 2. LF Univerzity Karlovy a Fakultní nemocnice Motol, Praha
5 Kardiocentrum, Nemocnice Na Homolce, Praha
6 Klinika anesteziologie, resuscitace a intenzivní medicíny, 1. LF Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha
7 Kardiocentrum, Nemocnice, a. s., České Budějovice
8 Kardiochirurgické oddělení, Fakultní nemocnice Plzeň
9 Klinika anesteziologie a resuscitace, Kardiocentrum, IKEM Praha
10 Klinika anesteziologie, resuscitace a intenzivní medicíny, LF Univerzity Karlovy a Fakultní nemocnice Hradec Králové
11 Kardiochirurgické centrum, Fakultní nemocnice Ostrava
12 Kardiochirurgická klinika, 3. LF Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha

Objective:
To obtain data about the use of neuromuscular blocking agents (NMBAs) during general anaesthesia in adult patients undergoing cardiac surgery in the Czech Republic.

Design:
A five-day, prevalence, questionnaire study.


Setting:
All cardiac anesthesia departments that registered before the study date.

Materials and methods:
Patients whose anesthetic care was provided between June 6 (7 AM) and June 11 (7 AM) were enrolled. Data of each patient were entered into a web-based questionnaire and information relevant to neuromuscular blockade was collected.

Results:
During the study period, 183 patients (173 on cardiopulmonary bypass) were anesthetized. Tracheal intubation (172 patients) was facilitated most often by non-depolarizing NMBAs: rocuronium (31.1%), pancuronium (16.9%), atracurium (14.8%), cisatracurium (13.7%), and suxamethonium 2.2%. Neuromuscular blockade was maintained most frequently with rocuronium (24.0%), cisatracurium (15.8%), pancuronium (12.0%), atracurium (14.8%), and vecuronium (11.5%). Neuromuscular blockade was not reversed in any patient. Monitoring of neuromuscular blockade was not used in any patient.

Conclusion:
For induction and maintenance of neuromuscular blockade, predominantly intermediate NMBAs were used. In the Czech Republic, neither neuromuscular blockade monitoring nor pharmacological reversal is used during cardiac surgery in adult patients.

Keywords: questionnaire survey; neuromuscular blockade; cardiac surgery; neuromuscular blocking agent; reversal; monitoring

Received: December 16, 2012; Accepted: January 15, 2012; Published: February 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hájek R, Adámek P, Derych L, Horáček M, Jehlička P, Kameník V, et al.. Kardiorelax 2011 - a five-day observational study of neuromuscular blockade during adult cardiac surgery in the Czech Republic. Anest. intenziv. Med. 2012;23(1):14-20.
Download citation

References

  1. Murphy, G. S., Szokol, J. W., Vender, J. S. The use of neuromuscular blocking drugs in adult cardiac surgery: results of national postal survey. Anesth. Analg., 2002, 95, p. 1534-1539. Go to original source... Go to PubMed...
  2. Černý, V., Adamus, M., Cvachovec, K., Ševčík, P., Herold, I. Anestezie v České republice 2010 - jednodenní prospektivní observační dotazníková studie. Anest. intenziv. Med., 2011, 22, p. 5-12.
  3. Adamus, M., Herold, I., Cvachovec, K., Ševčík, P., Černý, V. Svalová relaxace během celkové anestezie v České republice 2010 - jednodenní prospektivní observační dotazníková studie. Anest. intenziv. Med., 2011, 22, p. 82-89.
  4. McEwin, L., Merrick, P. M., Bevan, D. R. Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuronium. Can. J. Anaesth., 1997, 44, p. 891-895. Go to original source... Go to PubMed...
  5. Murphy, G. S., Szokol, J. W., Marymont, J. H. Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient. Anesthesiology, 2002, 96, p. 600-606. Go to original source... Go to PubMed...
  6. Hemmerling, T. M., Russo, G., Bracco, D. Neuromuscular blockade in cardiac surgery: An update for clinicians. Ann. Card. Anaesth., 2008, 11, p. 80-88. Go to original source... Go to PubMed...
  7. Virmani, S., Tempe, D. K., Datt, V. Effect of muscle relaxants on heart rate, arterial pressure, intubation condition and onset of neuromuscular block in patients undergoing valve surgery. Ann. Card. Anaesth., 2006, 9, p. 37-43. Go to original source... Go to PubMed...
  8. Cammu, G. How rational is muscle relaxation during cardiac surgery? Acta Anaesthesiol. Belg., 2007, 58, p. 7-14. Go to PubMed...
  9. Irish, C. L., Murkin, J. M., Cleland, A. Neuromuscular blockade significantly decreases systemic oxygen consumption during hypothermic cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth., 1991, 5, p. 132-134. Go to original source... Go to PubMed...
  10. Cammu, G., Cardinael, S., Lahousse, S. Muscle relaxation does not influence venous oxygen saturation during cardiopulmonary bypass. J. Clin. Anesth., 2007, 19, p. 105-109. Go to original source... Go to PubMed...
  11. Vernon, D. D., Witte, M. K. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Crit. Care Med., 2000, 28, p. 1569-1571. Go to original source... Go to PubMed...
  12. Lemson, J., Driessen, J. J., van der Hoeven, J. G. The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery. Intensive Care Med., 2008, 34, p. 2268-2272. Go to original source... Go to PubMed...
  13. Olivieri, L., Piourde, G. Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery. Report of two cases. Can. J. Anaesth., 2005, 52, p. 88-93. Go to original source... Go to PubMed...
  14. Buzzelo, W., Schiuermann, D., Pollmaecher, T. Unequal effects of cardiopulmoary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium and vecuronium. Anesthesiology, 1987, 66, p. 842-846. Go to original source... Go to PubMed...
  15. Smeulers, N. J., Vierda, J. M., van den Broek, L. Effects of hypothermic cardiopulmonary bypass on the farmacodynamics and pharmacokinetics of rocuronium. J. Cardiothorac. Vasc. Anaesth., 1995, 9, p. 700-705. Go to original source... Go to PubMed...
  16. Murphy, G. S., Szokol, J. W., Maymont, J. H. Recovery of neuromuscular function after cardiac surgery: Pancuronium vs rocuronium. Can. J. Anaesth., 1997, 44, p. 891-895. Go to original source... Go to PubMed...
  17. Cammu, G., Coddens, J., Hendrickx, J. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass. Br. J. Anaesth., 2000, 84, p. 587-590. Go to original source... Go to PubMed...
  18. Ouattara, A., Richard, L., Charriere, J. M. Use of cis-atracurium during fast-track cardiac surgery. Br. J. Anaesth., 2001, 86, p. 130-132. Go to original source... Go to PubMed...
  19. Gueret, G., Rossignol, B., Kiss, G. Is muscle relaxant necessary for cardiac surgery? Anaesth. Analg., 2004, 99, p. 1330-1333. Go to original source... Go to PubMed...
  20. van Vlymen, J. M., Parlow, J. L. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth. Analg., 1997, 84, p. 148-154. Go to original source...
  21. Adamus, M., Gabrhelik, T., Marek, O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur. J. Anaesthesiol., 2008, 25: p. 589-595. Go to original source... Go to PubMed...
  22. Kopman, A. F. Neuromuscular monitoring: Old issues, new controversies. J. Crit. Care, 2009, 24, p. 11-20. Go to original source... Go to PubMed...
  23. Fuchs-Buder, T., Schreiber, J.-U., Meistelman, C. Monitoring neuromuscular block: an update. Anaesthesia, 2009, 64, S1, p. 82-89. Go to original source... Go to PubMed...
  24. Cerny V, Herold I, Cvachovec K, Sevcik P, Adamus M. Guidelines for managing neuromuscular block: not only Czech beer deserves a taste. Anesth. Analg., 2011, 112, p. 482. Go to original source... Go to PubMed...
  25. Donati, F. Neuromuscular monitoring: what evidence do we need to be convinced? Anesth. Analg., 2010, 111, p. 6-8. Go to original source... Go to PubMed...
  26. Debaene, B., Plaud, B., Dilly, M. P., Donati, F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology, 2003, 98, p. 1042-1048. Go to original source... Go to PubMed...
  27. Murphy, G., Hessel, E., Groom R. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth. Analg., 2009, 108, p. 1394-1417. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.